Tislelizumab (Anti-PDCD1 / PD-1 / CD279)

Tislelizumab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1). It can be used for the research of advanced squamous non-small-cell lung cancer. MW :144.46 KD
Supplier Selleck Chemicals
Product # A3039
Sku # A3039-1mg*5
Pricing 1mg*5, $790.00
Feedback